SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-061773
Filing Date
2019-11-08
Accepted
2019-11-08 17:02:18
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919516d1_10q.htm 10-Q 699739
2 EXHIBIT 31.1 tm1919516d1_ex31-1.htm EX-31.1 7366
3 EXHIBIT 31.2 tm1919516d1_ex31-2.htm EX-31.2 7298
4 EXHIBIT 32.1 tm1919516d1_ex32-1.htm EX-32.1 4219
5 EXHIBIT 32.2 tm1919516d1_ex32-2.htm EX-32.2 3939
  Complete submission text file 0001104659-19-061773.txt   3879958

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20190930.xml EX-101.INS 783445
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20190930.xsd EX-101.SCH 39543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20190930_cal.xml EX-101.CAL 31224
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20190930_def.xml EX-101.DEF 131530
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20190930_lab.xml EX-101.LAB 294838
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20190930_pre.xml EX-101.PRE 249867
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 191204831
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences